NDC Code(s) : 60505-6144-4, 60505-6145-4
Packager : Apotex Corp.
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
CefepimeCefepime INJECTION, POWDER, FOR SOLUTION | ||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
CefepimeCefepime INJECTION, POWDER, FOR SOLUTION | ||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
LABELER - Apotex Corp.(845263701) |
REGISTRANT - Qilu Pharmaceutical Co., Ltd.(653878256) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
Qilu Pharmaceutical Co., Ltd. (High-Tech Zone Site) | 421279342 | manufacture(60505-6144, 60505-6145), analysis(60505-6144, 60505-6145) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
Qilu Antibiotics Pharmaceutical Co., Ltd. | 527271779 | manufacture(60505-6144, 60505-6145), analysis(60505-6144, 60505-6145) |
PRINCIPAL DISPLAY PANEL
Single-Dose Vial NDC 60505-6144-0
Cefepime for Injection, USP
1 gram per vial
Reconstitute before Intramuscular Use.
Dilute before Intravenous Infusion.
Rx Only
NOVAPLUS®
PRINCIPAL DISPLAY PANEL
Single-Dose Vial NDC 60505-6145-0
Cefepime for Injection, USP
2 grams per vial
Dilute before Intravenous Infusion.
Rx Only
NOVAPLUS®
PRINCIPAL DISPLAY PANEL
10*1 gram Single-Dose Vials NDC 60505-6144-4
Cefepime for Injection, USP
1 gram per vial
Reconstitute before Intramuscular Use.
Dilute before Intravenous Infusion.
Protect from Light. Retain in Carton Until Time of Use.
Rx Only
NOVAPLUS®
PRINCIPAL DISPLAY PANEL
10*2 gram Single-Dose Vials NDC 60505-6145-4
Cefepime for Injection, USP
2 grams per vial
Dilute before Intravenous Infusion.
Protect from Light. Retain in Carton Until Time of Use.
Rx Only
NOVAPLUS®